All the latest news on the marijuana space delivered directly to your inbox.
TheSeedInvestor
Read our Investor Dashboard on OTC:ABCCF TSX.v ABCN
There will be a sudden wave of "Marijuana Millionaires" in 2017 - will you be one?

 
13x13x1 READ MORE
How To Invest in the Emerging Marijuana Market.
 
LEARN MORE
600x300
Analysts Are Seeing A Bullish Move for InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF)

InMed Pharmaceuticals, Inc. (CSE: IN; OTCQB: IMLFF), has seen a strong upward trend over the past few weeks, going from a close of $.27 at the end of August to $.50 currently on the back of strong announcements, and people are taking notice.

13x13x1 READ MORE
600x300
14 More States That Might Legalize Cannabis This Year - Culture

So much marijuana reform, so much time left on the calendar in 2017. Arizona, Connecticut, Hawaii, Kentucky, Maryland, Mississippi, Missouri, New Hampshire, New Jersey, New Mexico, New York, Pennsylvania, Texas, Wyoming, and Washington, D.C. all have strong policymakers working to actively legalize and regulate cannabis. When passed, these 14 states will follow in the footsteps of Alaska, California, Colorado, Maine, Massachusetts, Nevada, Oregon, and Washington.

13x13x1 READ MORE
600x300
Khiron Appoints Former DEA Chief of Pharmaceutical Investigations to Advisory Board

Khiron Life Sciences Corp. reports the appointment of Mr. Matthew Murphy, the former U.S. Drug Enforcement Administration (“DEA”) Chief of Pharmaceutical Investigations, to the Advisory Board of the Company.

 

13x13x1 READ MORE
600x300
California regulator admits to anxiety as recreational marijuana deadline nears

In about three months, recreational marijuana sales will kick off in California, yet no one knows exactly how the pot economy will work.

It could take until late November for the state to issue regulations that will govern the new marketplace.

13x13x1 READ MORE
Please see full disclaimers on the TheSeedInvestor.com website applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimerDisclaimer.

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed inv­estment advisor. 

 
32x32x1   32x32x2  
TheSeedInvestor.com
9375 E Shea Blvd Ste 100
Scottsdale 85260
info@theseedinvestor.com
 
©2019, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.